Ventilator Associated Tracheobronchitis in the First 14 Days in ICU

To investigate the clinical course and risk factors for VAT and the impact of VAT on Intensive Care Unit (ICU) morbidity and mortality.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Airway Colonization Infections Lung Diseases Pneumonia Respiratory Tract Diseases Respiratory Tract Infections Tracheobronchitis and Pneumonia Associated With Ventilator

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

> 48 hours mechanical ventilation

Exclusion criteria

immunodeficiency
pregnancy
severe COPD, chronic bronchitis, bronchiectasis
recent pneumonia

Treatment and study plan

Primary outcomes

mortality

Time frame: mortality at 4 weeks

we assessed mortality from all causes at 4 weeks

Secondary outcomes

ICU length of stay

Time frame: expected average length of stay 15 days
mortality at 6 months

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

University of Thessaly

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Mar 1, 2013
Registry last updated: Mar 1, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed